These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 692284)

  • 21. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
    Korpi ER; Wyatt RJ
    Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN; Roth KA; Agren H; Barchas JD
    Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain.
    Kashihara K; Sato M; Fujiwara Y; Harada T; Ogawa T; Otsuki S
    Biol Psychiatry; 1986 Jun; 21(7):650-6. PubMed ID: 3011131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Endorphin-induced increase in striatal dopamine turnover.
    van Loon GR; Kim C
    Life Sci; 1978 Sep; 23(9):961-70. PubMed ID: 703526
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
    Uretsky NJ; Snodgrass SR; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
    Ichikawa J; Meltzer HY
    Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.
    Karoum F; Egan MF
    Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC
    Experientia; 1980 Sep; 36(9):1092-4. PubMed ID: 6448165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propentofylline (HWA285) inhibits the release of dopamine during transient ischemia and modulates its metabolism in rat striatum.
    Shimizu K; Ogino M; Yamaguchi N; Mitani S; Saito R; Kawase T; Toya S
    Neurosci Lett; 1993 Aug; 158(1):9-12. PubMed ID: 8233079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
    See RE
    Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preservation of dopamine release in the denervated striatum.
    Altar CA; Marien MR
    Neurosci Lett; 1989 Jan; 96(3):329-34. PubMed ID: 2497410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.